Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer

Breast cancer is a global health threat and cases diagnosed in women during the years after childbirth, or postpartum breast cancers (PPBCs), have high risk for metastasis. In preclinical murine models, semaphorin 7a (SEMA7A) drives the metastatic potential of postpartum mammary tumors. Thus, we hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges, Virginia F., Hu, Junxiao, Young, Chloe, Maggard, Jaron, Parris, Hannah J., Gao, Dexiang, Lyons, Traci R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572422/
https://www.ncbi.nlm.nih.gov/pubmed/33088913
http://dx.doi.org/10.1038/s41523-020-00198-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572422/
https://www.ncbi.nlm.nih.gov/pubmed/33088913
http://dx.doi.org/10.1038/s41523-020-00198-1

Ejemplares similares